Question 1

What is Kyowa Kirin?

Accepted Answer

Kyowa Kirin is a Company.

Question 2

How often does Kyowa Kirin appear in global news?

Accepted Answer

Tracked across 3 news events drawn from 19 articles.

Question 3

When was Kyowa Kirin first tracked by Ergen?

Accepted Answer

First tracked on Apr 01, 2026.

Question 4

When was Kyowa Kirin last mentioned in news?

Accepted Answer

Last active on Jun 30, 2026.

Question 5

What is Kyowa Kirin's current news sentiment?

Accepted Answer

Aggregate sentiment score: 48 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Kyowa Kirin in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 3 events.

Question 7

What is the most recent event involving Kyowa Kirin?

Accepted Answer

Kyowa Kirin Mogamulizumab PROSPER Results (Jun 29, 2026, 7 articles).

Question 8

How did the "Kyowa Kirin Mogamulizumab PROSPER Results" event impact Kyowa Kirin?

Accepted Answer

Kyowa Kirin announced positive results from its PROSPER study for mogamulizumab, which is expected to positively impact its stock price and reputation.

Question 9

How did the "Kyowa Kirin's Mogamulizumab Improves Survival" event impact Kyowa Kirin?

Accepted Answer

Kyowa Kirin funded the research and developed mogamulizumab, a drug that showed improved survival outcomes in patients with rare blood cancers, positively impacting the company's reputation and potential market position for its product POTELIGEO.

Question 10

How did the "Ardelyx Appoints Rajani Dinavahi CMO" event impact Kyowa Kirin?

Accepted Answer

Kyowa Kirin commercializes PHOZEVEL (tenapanor) for hyperphosphatemia in Japan, a product related to Ardelyx's pipeline.

Question 11

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.